Yujie Zhu[Author] - Search Results

Year	Number of Results
2004	1
2005	1
2006	2
2007	5
2008	1
2010	1
2012	5
2013	12
2014	4
2015	9
2016	9
2017	12
2018	9
2019	18
2020	18
2021	36
2022	31
2023	41
2024	10

1

NAD⁺ rescues aging-induced blood-brain barrier damage via the CX43-PARP1 axis.

Zhan R, Meng X, Tian D, Xu J, Cui H, Yang J, Xu Y, Shi M, Xue J, Yu W, Hu G, Li K, Ge X, Zhang Q, Zhao M, Du J, Guo X, Xu W, Gao Y, Yao C, Chen F, Chen Y, Shan W, Zhu Y, Ji L, Pan B, Yu Y, Li W, Zhao X, He Q, Liu X, Huang Y, Liao S, Zhou B, Chui D, Chen YE, Sun Z, Dong E, Wang Y, Zheng L. Zhan R, et al. Among authors: zhu y. Neuron. 2023 Nov 15;111(22):3634-3649.e7. doi: 10.1016/j.neuron.2023.08.010. Epub 2023 Sep 7. Neuron. 2023. PMID: 37683629

2

Polynucleotide phosphorylase protects against renal tubular injury via blocking mt-dsRNA-PKR-eIF2α axis.

Zhu Y, Zhang M, Wang W, Qu S, Liu M, Rong W, Yang W, Liang H, Zeng C, Zhu X, Li L, Liu Z, Zen K. Zhu Y, et al. Nat Commun. 2023 Mar 3;14(1):1223. doi: 10.1038/s41467-023-36664-0. Nat Commun. 2023. PMID: 36869030 Free PMC article.

3

Rational Design of Biomaterials to Potentiate Cancer Thermal Therapy.

Zhu Y, Li Q, Wang C, Hao Y, Yang N, Chen M, Ji J, Feng L, Liu Z. Zhu Y, et al. Chem Rev. 2023 Jun 14;123(11):7326-7378. doi: 10.1021/acs.chemrev.2c00822. Epub 2023 Mar 13. Chem Rev. 2023. PMID: 36912061 Review.

4

Gut microbiome and metabolites, the future direction of diagnosis and treatment of atherosclerosis?

Cao H, Zhu Y, Hu G, Zhang Q, Zheng L. Cao H, et al. Among authors: zhu y. Pharmacol Res. 2023 Jan;187:106586. doi: 10.1016/j.phrs.2022.106586. Epub 2022 Nov 30. Pharmacol Res. 2023. PMID: 36460280 Free article. Review.

5

Regulatory of miRNAs in tri-lineage differentiation of C3H10T1/2.

Huang W, Wu X, Xiang S, Qiao M, Li H, Zhu Y, Zhu Z, Zhao Z. Huang W, et al. Among authors: zhu y. Stem Cell Res Ther. 2022 Nov 22;13(1):521. doi: 10.1186/s13287-022-03205-3. Stem Cell Res Ther. 2022. PMID: 36414991 Free PMC article. Review.

6

LincRNA-ROR/miR-145/ZEB2 regulates liver fibrosis by modulating HERC5-mediated p53 ISGylation.

Shen J, Wang Z, Liu M, Zhu YJ, Zheng L, Wang LL, Cheng JL, Liu TT, Zhang GD, Yang TY, Wang X, Zhang L. Shen J, et al. FASEB J. 2023 Jun;37(6):e22936. doi: 10.1096/fj.202201182RR. FASEB J. 2023. PMID: 37144417

7

Structure, bioactivity and applications of natural hyperbranched polysaccharides.

Chen L, Ge MD, Zhu YJ, Song Y, Cheung PCK, Zhang BB, Liu LM. Chen L, et al. Carbohydr Polym. 2019 Nov 1;223:115076. doi: 10.1016/j.carbpol.2019.115076. Epub 2019 Jul 10. Carbohydr Polym. 2019. PMID: 31427017 Review.

8

Editor's preface.

Zhong G, Zhu Y. Zhong G, et al. Among authors: zhu y. J Cardiovasc Dis Res. 2013 Sep;4(3):163. doi: 10.1016/j.jcdr.2013.09.001. J Cardiovasc Dis Res. 2013. PMID: 24396254 Free PMC article. No abstract available.

9

Recent Advances in the Applications of Water-soluble Resorcinarene-based Deep Cavitands.

Zhu YJ, Zhao MK, Rebek J Jr, Yu Y. Zhu YJ, et al. ChemistryOpen. 2022 Jun;11(6):e202200026. doi: 10.1002/open.202200026. ChemistryOpen. 2022. PMID: 35701378 Free PMC article. Review.

10

Efferocytosis Nanoinhibitors to Promote Secondary Necrosis and Potentiate the Immunogenicity of Conventional Cancer Therapies for Improved Therapeutic Benefits.

Wu Y, Wang C, Yan Y, Hao Y, Liu B, Dong Z, Chen M, Zhu Y, Liu N, Feng L, Liu Z. Wu Y, et al. Among authors: zhu y. ACS Nano. 2023 Sep 26;17(18):18089-18102. doi: 10.1021/acsnano.3c04884. Epub 2023 Sep 5. ACS Nano. 2023. PMID: 37669546

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

196 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

196 results

Results by year